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Introduction
Gastrointestinal stromal tumors (GIST) are rare 
lesions comprising about 1% of neoplasms of the 
gastrointestinal tract [1]. They are usually localized 
in the stomach (60%), but they can involve the small 
intestine (30%), large intestine (4%), or esophagus 
(< 1%) [2, 3]. Even rarer cases of GIST developing 
outside of the GI tract (extragastrointestinal stromal 
tumors – EGISTs), in organs such as the pancreas, 
gallbladder, urinary bladder, or omentum, are de-
scribed [4]. The mainstay of treatment of GIST is sur-
gery based on resection of the lesion with a healthy 
tissue margin [5]. 
Below we present a case of a patient with GIST 
located in the uncinate process of the pancreas that 
was treated successfully with a  laparoscopic tech-
nique. 
Case report
A  55-year-old man came to our clinic because 
of a 1.5 cm pancreatic tumor that was accidentally 
found during a computed tomography examination 
(Photo 1). At that time the patient was completely 
asymptomatic. In order to widen the diagnostics he 
was referred for magnetic resonance imaging study 
of the abdominal cavity. In that examination a lesion 
sized 20 × 17 × 16 located in the uncinate process of 
the pancreas was found. It intensified significantly 
after intravenous contrast administration (Photo 2). 
The image primarily suggested a  neuroendocrine 
tumor. To confirm the diagnosis, scintigraphy was 
performed using a  marked somatostatin analogue 
(99MTC). The examination confirmed the presence of 
an area of higher expression of somatostatin recep-
tors located in the uncinate process of the pancreas 
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A b s t r a c t
The pancreas is an extremely rare location for gastrointestinal stromal tumors (GIST). We present a case of a pa-
tient with a GIST located in the uncinate process of the pancreas that was treated successfully with a laparoscopic 
technique. Computed tomography, magnetic resonance imaging and scintigraphy suggested a neuroendocrine tu-
mor. Due to the fact that the image suggested a neuroendocrine tumor with a diameter below 2 cm, the patient 
was qualified for a laparoscopic procedure of tumor enucleation. Postoperative care proceeded in accordance with 
the principles of the ERAS concept. The postoperative course was uncomplicated. He was discharged home on the 
second postoperative day. In the obtained histopathology result a GIST was found. During a 6-month observation, 
including control computed tomography examination, no signs of tumor progression were found. Despite the fact 
that stromal tumors of the gastrointestinal tract localized in the pancreas are very rare, they should be considered in 
the differential diagnosis of tumors of this organ.
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(Photo 3). In the imaging studies no distal lesions 
were found within the abdominal cavity. No cancer 
markers were elevated either. Due to the fact that 
the image suggested a neuroendocrine tumor with 
a diameter below 2 cm, the patient was qualified for 
a laparoscopic procedure of tumor enucleation. The 
procedure was performed using 5 ports (Figure 1). 
Intraoperative ultrasound was performed, visual-
izing a 15 mm hypoechogenic structure within the 
uncinate process of the pancreas, which was then 
enucleated completely and sent for histopathologic 
verification (Photos 4 and 5). No drain was left in 
the abdominal cavity. Postoperative care proceeded 
in accordance with the principles of the ERAS con-
cept [6]. A few hours after the procedure the patient 
started to walk around. During the first 24 h drinks 
and a fluid diet were administered. The further post-
operative course was uncomplicated. The patient 
Photo 1. Computed tomography image showing 
a tumor in the area of the uncinate process of 
the pancreas
Photo 2. Magnetic resonance imaging image 
showing a lesion in the uncinate process of the 
pancreas sized 20 × 17 × 16 mm, which signifi-
cantly intensified after intravenous contrast ad-
ministration
Figure 1. Trocar placement during the procedure
Photo 3. Scintigraphy with a marked somatosta-
tin analogue (99MTC) confirming presence of an 
area of increased expression of somatostatin re-
ceptors localized in the uncinate process of the 
pancreas
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required use of small doses of nonsteroidal anti-in-
flammatory drugs (NSAIDs) due to moderately se-
vere abdominal pain. He was discharged home on 
the second postoperative day. In the obtained histo-
pathology result a GIST was found (Photos 6 and 7) 
with a diameter of 1.8 cm and 1 figure of mitotic di-
vision per 50 high power fields of view (Table I). The 
risk of tumor progression assessed according to the 
Joensuu criteria was defined as low. The histopatho-
logic examination confirmed an R0 resection. Be-
cause of this, it was decided not to widen the margin 
of excision, even though the resection margin was 
smaller than 10 mm. During 6 months of observa-
tion, including control computed tomography exam-
ination, no signs of tumor progression were found.  
Discussion
The GIST are rare lesions, and their occurrence 
outside of the gastrointestinal tract (EGIST) is sporad-
Photo 4. Intraoperative image of the tumor. 
Stage of tumor enucleation from the uncinate 
process of the pancreas
Table I. Pathological characteristics of the re-
moved tumor
Tumor diameter 18 mm
Histological type Fusiform
Number of mitoses 1/50 hpf
Immunohistochemical phenotype CD117 +, S100 +, 
SMA +
Risk of progression according to Joensuu Very low
Photo 5. Intraoperative image of the tumor. 
Completely enucleated tumor
Photo 6. Microscopic image of the removed tu-
mor. Fusiform GIST cells together with a neigh-
boring strand of fibrous tissue
Photo 7. Microscopic image of the removed tu-
mor. Positive immunohistochemical staining for 
CD 117
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ic. These neoplasms may also be located in the uri-
nary bladder, omentum, gallbladder, or retroperitone-
al space and pancreas, among other locations [4, 7].
Most pancreatic tumors are lesions of epitheli-
al origin. Neuroendocrine tumors comprise a small 
percentage of lesions of this organ [8]. The pancreas 
is an extremely rare location for EGIST. So far about 
20 cases of neoplasms of this type localized in the 
pancreas have been described [9]. 
The mainstay of GIST treatment is surgical 
treatment based on a radical excision of the lesion 
with a  macroscopically healthy tissue border with 
a  1–2  cm margin. Unlike malignant tumors of ep-
ithelial origin, removal of the regional lymphatic 
system seems unnecessary, because neoplasms 
of the GIST type very rarely metastasize to lymph 
nodes [10]. Such characteristics encourage the 
use of minimally invasive techniques in treatment 
of these neoplasms [11]. Most cases of pancreatic 
EGIST described in the literature were large lesions 
[9]. In more than a half of them the tumor diameter 
was over 10 cm, and the lesion itself often extended 
beyond the pancreas. Because of that, the surgical 
treatment involved extensive resection procedures 
with the classical method. However, in the case de-
scribed by us the pancreatic tumor was small. We 
decided on enucleation of the lesion because the 
preoperative tests suggested presence of a NET type 
tumor with a diameter below 2 cm. The small size 
of the lesion and lack of infiltration of neighboring 
tissues allowed the use of laparoscopy, even though 
the tumor was located in the uncinate process of the 
pancreas, which from the anatomical point of view 
seems to be a place that is hard to reach in surgery. 
The lesion was removed with a small healthy tissue 
margin, because its widening would be connected 
with the need of pancreaticoduodenectomy. Accord-
ing to our knowledge the procedure performed by us 
is the first surgery of that kind performed within the 
pancreas due to GIST.
Due to a small number of pancreatic GIST cases 
described in the literature we only have rudimenta-
ry information concerning the results of treatment 
of these tumors. However, existing scientific papers 
comparing laparoscopic treatment of stomach GIST 
with the procedures performed using the classic 
method suggest that the minimally invasive treat-
ment allows similar results to be obtained in terms 
of oncology, and at the same time, it is linked with 
a  smaller perioperative injury, less blood loss, and 
a quicker recovery of proper function of the gastro-
intestinal tract. It shortens the time of hospitaliza-
tion and reduces the risk of complications [12]. Due 
to the very rare occurrence in the literature there is 
a lack of scientific research documenting the advan-
tage of one method over the other in the case of 
GIST localized in the pancreas.
In the case described by us, perioperative pro-
cedures according to the ERAS concept were imple-
mented [6]. Postoperative care based on the prin-
ciples of, among others, early mobilization of the 
patient, early administration of per os feeding and 
optimal analgesia, allowed the patient to be dis-
charged home within 48 h of the procedure.
Clinically, stromal tumors of the gastrointestinal 
tract are characterized by a  high variability. They 
range from small lesions with a  slow, almost sta-
tionary course, recognized often accidentally during 
endoscopic examinations or surgical procedures, to 
tumors with a  very aggressive clinical picture with 
multiple metastases at the time of diagnosis [13]. 
Basic criteria allowing the determination of the de-
gree of GIST malignancy include characteristics such 
as tumor size, value of the mitotic index, and lesion 
location [1, 14]. Available literature suggests that 
GIST located in the stomach are characterized by 
a better prognosis than GIST in other locations. The 
limited quantity of data does not allow us to clearly 
determine the prognosis in the case of pancreatic 
GIST. However, in accordance with the above infor-
mation it can be suspected that GIST of the pancre-
as have a  worse prognosis than lesions located in 
the stomach. This necessitates special oncological 
caution in future follow-ups. In the case presented 
by us, the tumor was characterized by a low degree 
of malignancy and was radically removed. However, 
the short follow-up period does not allow the as-
sessment of long-term treatment. 
Conclusions
Despite the fact that stromal tumors of the gas-
trointestinal tract localized in the pancreas are very 
rare, they should be considered in the differential di-
agnosis of tumors of this organ. The case described 
by us is an example showing that minimally inva-
sive procedures can be used in the treatment of this 
type of tumor within the pancreas. Nevertheless, it is 
necessary for the operator to have significant expe-
rience and proficiency in surgical procedures due to 
oncological indications. Also, patients should remain 
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under constant postoperative care, irrespective of 
the degree of tumor malignancy.   
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